FDA Inspection 1100673 — Equity Group Eufaula Division LLC
The FDA completed an inspection of Equity Group Eufaula Division LLC on August 14, 2019 in Banks, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 14, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Banks, AL (United States)